# Effect of long-term inorganic nitrate administration on myocardial ischemia-reperfusion injury in ovariectomized rats

**Authors:** Sajad Jeddi, Nasibeh Yousefzadeh, Maryam Zarkesh, Khosrow Kashfi, Asghar Ghasemi

PMC · DOI: 10.3389/fphar.2024.1369379 · 2024-03-27

## TL;DR

Long-term nitrate administration protects the hearts of ovariectomized rats from injury during ischemia-reperfusion by improving antioxidant activity and reducing harmful cellular processes.

## Contribution

This study demonstrates that long-term nitrate administration mitigates myocardial ischemia-reperfusion injury in ovariectomized rats through eNOS upregulation and reduced oxidative stress and apoptosis.

## Key findings

- Nitrate increased catalase activity and eNOS expression in non-injured hearts.
- Nitrate reduced infarct size and improved cardiac function in ischemia-reperfusion injured hearts.
- Nitrate decreased oxidative stress markers and apoptosis-related gene expression in heart tissue.

## Abstract

Introduction: Menopause is associated with reduced nitric oxide (NO) bioavailability and lower tolerance against myocardial ischemia-reperfusion (IR) injury. This study investigated whether long-term nitrate administration provides resistance against myocardial IR injury in ovariectomized (OVX) rats.

Method: After ovariectomy, female rats were assigned to the OVX and the OVX + nitrate groups (n = 14/group); the latter group consumed nitrate (100 mg/L) for 9 months. At month 9, each group was divided into two subgroups (n = 7/subgroup), of which one subgroup was exposed to myocardial IR (IR+ hearts) and the other was not exposed (IR− hearts). The hearts of rats were isolated, and NO metabolite (NOx), oxidative stress indices, and mRNA expressions of endothelial (eNOS), inducible (iNOS), and neuronal (nNOS) NO synthases, as well as markers of apoptosis, were measured in the IR− and IR+ hearts. In the IR+ hearts, cardiac function indices (CFI) and the infarct size were also measured.

Results: Nitrate increased catalase activity (97%) and eNOS expression (2.94-fold) in the IR− hearts. In the IR+ hearts, nitrate reduced left ventricular (LV) end-diastolic pressure (11.6%) and infarct size (26.2%) and increased recovery of LV developed pressure (44.0%) and peak rate of positive (28.9%) and negative (15.4%) changes in LV pressure. In addition, in the IR+ hearts, nitrate increased eNOS and B-cell lymphoma-2 (Bcl-2) as well as decreased iNOS, Bcl-2 associated X protein (Bax), caspase-3, caspase-8, caspase-9, and tumor necrosis factor-α (TNF-α) expression. Nitrate increased total antioxidant capacity (TAC) and catalase (CAT) activity and decreased malondialdehyde (MDA) levels at month nine in serum and IR+ hearts.

Conclusion: The favorable effects of nitrate against IR injury were associated with higher eNOS and Bcl-2 expression, CAT activity, TAC, and lower iNOS, Bax, caspase-3, caspase-8, caspase-9 and TNF-α expression, and MDA in the heart tissue. Nitrate preconditioning alleviated IR-induced myocardial injury in OVX rats; this effect was associated with eNOS upregulation before IR and the blunting of OVX-induced eNOS downregulation, iNOS upregulation, apoptosis, and oxidative stress in heart tissue after IR.

## Linked entities

- **Genes:** NOS3 (nitric oxide synthase 3) [NCBI Gene 4846], NOS2 (nitric oxide synthase 2) [NCBI Gene 4843], NOS1 (nitric oxide synthase 1) [NCBI Gene 4842], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], Casp3 (caspase 3) [NCBI Gene 12367], casp8 (caspase 8, apoptosis-related cysteine peptidase) [NCBI Gene 58022], Casp9 (caspase 9) [NCBI Gene 12371], TNF (tumor necrosis factor) [NCBI Gene 7124]
- **Chemicals:** nitrate (PubChem CID 943), NO (PubChem CID 24822), malondialdehyde (PubChem CID 10964)
- **Species:** Rattus norvegicus (taxon 10116)

## Full-text entities

- **Genes:** NOS1 (nitric oxide synthase 1) [NCBI Gene 4842] {aka IHPS1, N-NOS, NC-NOS, NOS, bNOS, nNOS}, CASP9 (caspase 9) [NCBI Gene 842] {aka APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, CAT (catalase) [NCBI Gene 847], BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, NOS2 (nitric oxide synthase 2) [NCBI Gene 4843] {aka HEP-NOS, INOS, NOS, NOS2A}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, CASP8 (caspase 8) [NCBI Gene 841] {aka ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5}, BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}
- **Diseases:** Menopause (MESH:D008594), IR injury (MESH:D015427), myocardial ischemia- (MESH:D017202), myocardial injury (MESH:D009202), infarct (MESH:D007238)
- **Chemicals:** NO (MESH:D009569), MDA (MESH:D008315), NOx (-), Nitrate (MESH:D009566)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11004245/full.md

---
Source: https://tomesphere.com/paper/PMC11004245